Tharimmune announces upcoming conference presentations

Bridgewater, nj / accesswire / november 4, 2024 / tharimmune, inc. (nasdaq:thar) ("tharimmune" or the "company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announces that management will be participating in two upcoming conferences. randy milby, chief executive officer, will attend the 2024 spartan capital investor conference being held on november 4, 2024 in new york and hold one-on-one meetings.
THAR Ratings Summary
THAR Quant Ranking